Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s approval of Dsuvia and the FDA’s future consideration of new opioids
FDA announces approval of Dsuvia and new steps the agency may be taking to evaluate opioids.
FDA announces approval of Dsuvia and new steps the agency may be taking to evaluate opioids.